Young Li
Stock Analyst at Jefferies
(0.84)
# 4,453
Out of 5,182 analysts
8
Total ratings
60%
Success rate
-16.73%
Average return
Main Sectors:
Stocks Rated by Young Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STAA STAAR Surgical Company | Maintains: Buy | $28 → $22 | $26.44 | -18.68% | 1 | Jan 28, 2026 | |
| TMDX TransMedics Group | Initiates: Buy | $145 | $114.00 | +27.19% | 1 | Oct 13, 2025 | |
| RXST RxSight | Downgrades: Hold | $24 → $9 | $6.83 | +31.77% | 2 | Jul 10, 2025 | |
| COO The Cooper Companies | Upgrades: Buy | $107 → $115 | $71.21 | +61.49% | 1 | Jul 16, 2024 | |
| HYPR Hyperfine | Initiates: Hold | $1.25 | $1.22 | +2.88% | 1 | Nov 30, 2023 | |
| ENOV Enovis | Initiates: Buy | $60 | $24.42 | +145.70% | 1 | Oct 12, 2022 | |
| ANIK Anika Therapeutics | Initiates: Neutral | $46 | $14.76 | +211.65% | 1 | Jul 16, 2021 |
STAAR Surgical Company
Jan 28, 2026
Maintains: Buy
Price Target: $28 → $22
Current: $26.44
Upside: -18.68%
TransMedics Group
Oct 13, 2025
Initiates: Buy
Price Target: $145
Current: $114.00
Upside: +27.19%
RxSight
Jul 10, 2025
Downgrades: Hold
Price Target: $24 → $9
Current: $6.83
Upside: +31.77%
The Cooper Companies
Jul 16, 2024
Upgrades: Buy
Price Target: $107 → $115
Current: $71.21
Upside: +61.49%
Hyperfine
Nov 30, 2023
Initiates: Hold
Price Target: $1.25
Current: $1.22
Upside: +2.88%
Enovis
Oct 12, 2022
Initiates: Buy
Price Target: $60
Current: $24.42
Upside: +145.70%
Anika Therapeutics
Jul 16, 2021
Initiates: Neutral
Price Target: $46
Current: $14.76
Upside: +211.65%